Try our Advanced Search for more refined results

Expert Analysis

Takeaways From HHS Pharma Compliance Roundtable

Law360, New York (April 9, 2012, 1:40 PM EDT) -- On March 26, 2012, the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services released a report summarizing its recent Pharmaceutical Compliance Roundtable.[1] The report provides a generally favorable account of the challenges and concerns raised by industry participants and the efforts they are making to implement effective compliance programs and comply with their respective Corporate Integrity Agreements (CIAs). Although the report implicitly validates industry concerns about the need for greater flexibility and about the costs associated with CIA requirements, it also foreshadows areas where the OIG may be looking to tighten requirements in the future....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!